The Michael J. Fox Foundation (MJFF) awarded the 2022 Robert A. Pritzker Prize for Leadership in Parkinson's Research to J. Timothy Greenamyre, MD, PhD, Professor and Vice-Chair of Neurology and Director of the Pittsburgh Institute for Neurodegenerative Diseases at the University of Pittsburgh. Established in 2011, the prize recognizes researchers who make exceptional contributions to Parkinson's disease (PD) research and are committed to mentoring the next generation of Parkinson's scientists.
Greenamyre’s research trailblazed areas of science that are key to our understanding of genetic and environmental factors as well as the role of mitochondria in PD. His research informs preventative efforts to ban potential causes of PD, while also informing potential targets for PD treatments. Through it all, Greenamyre remains dedicated to the clinical impact of his work and continues to provide care for his patients whilst conducting research.
“Dr. Greenamyre stands out for his expansive research in Parkinson’s disease, especially on the intersection of genetics and environment. This science has and will continue to resonate through the field,” said MJFF’s Executive Vice President, Research Strategy Todd Sherer, PhD. “Beyond that, there's a broad network of people that he has mentored who are continuing to make significant impact in Parkinson's. He always treated that group as a family and empowered them to make meaningful progress in the field.”
“The Robert A. Pritzker Prize for Leadership in Parkinson's Research has recognized, annually, some of the most amazing Parkinson's scientists around the world. To be among those who have been recognized is humbling,” said Greenamyre. “My relationship with my patients is what motivates me. Working with these families over many years and seeing the impact of the disease drives my dedication to identify causal factors and biological contributors toward therapies and policies to stop Parkinson’s. To have those efforts recognized with this prize is an honor.”
Sherer presented the prize to Greenamyre at the Foundation’s Research Roundtable event in New York City on October 29, 2022.